Skip to main content
All lobbying filings

STEALTH BIOTHERAPEUTICS INC.

Lobbying for STEALTH BIOTHERAPEUTICS INC. · Developing therapies to treat mitochondrial dysfunction.

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $110,000.00 expenses · posted Oct 20, 2025

Official filing document

 Bills named in this filing 15
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
  • S 752
    Accelerating Kids’ Access to Care Act
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • S 932
    Give Kids a Chance Act of 2025
  • S 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • HR 1532
    Scientific EXPERT Act of 2025
  • S 822
    Scientific EXPERT Act of 2025
  • HR 946
    ORPHAN Cures Act
  • S 1862
    ORPHAN Cures Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 4121
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  • S 2256
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
  • HR 7384
    Creating Hope Reauthorization Act of 2024
  • S 4583
    Creating Hope Reauthorization Act of 2024
  • HR 1092
    BENEFIT Act of 2023
 Lobbying activity 1
Health Issues

H.R. 7384/S. 4583, the Creating Hope Reauthorization Act of 2024 (118th Congress) H.R. 1509/S. 752 the Accelerating Kids Access to Care Act H.R. 1262/S. 932 - Give Kids a Chance Act of 2025 General discussions about ultra-rare disease drug development General discussions about regulatory reform, including scientific-focused drug development meetings H.R. 1092/S. 526, the BENEFIT Act (118th Congress) General discussions about mitochondrial diseases H.R. 1532/S. 822, the Scientific EXPERT Act of 2025 General discussions about ultra-rare diseases FDA Rare Disease Innovation Hub ORPHAN Cures Act (H.R. 946 / S. 1862) [part of One, Big, Beautiful Bill Act (H.R 1)] Fiscal Year 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R. 4121 / S. 2256)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem